ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 315

$424K Total Retail Price of All Prescriptions

Rank: 97 out of 315

338 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 338 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 7,765 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
AMLODIPINE BESYLATE 725 686 1 2
LOSARTAN POTASSIUM 498 438 2 4
PRAVASTATIN SODIUM 422 400 3 10
SIMVASTATIN 360 334 4 1
CARVEDILOL 347 342 5 22
LISINOPRIL 316 307 6 3
GLIMEPIRIDE 298 296 7 32
ATORVASTATIN CALCIUM 257 235 8 5
AMLODIPINE BESYLATE-BENAZEPRIL 207 207 9 26
ALENDRONATE SODIUM 194 180 10 12
FAMOTIDINE 190 180 11 75
LEVOTHYROXINE SODIUM 167 155 12 6
ALLOPURINOL 149 136 13 14
LOVASTATIN 142 121 14 8
GLYBURIDE-METFORMIN HCL 127 117 R 15 87
LOSARTAN-HYDROCHLOROTHIAZIDE 107 106 16 17
DIOVAN 105 105 17 27
EVISTA 104 104 18 48
METFORMIN HCL 103 69 19 7
FELODIPINE ER 92 92 20 23
HYDROCHLOROTHIAZIDE 89 79 21 16
METOPROLOL SUCCINATE 87 81 22 13
ATENOLOL 83 71 23 11
ONGLYZA 81 76 24 99
FENOFIBRATE 81 65 24 43
CALCITONIN-SALMON 76 76 26 162
FUROSEMIDE 75 72 27 15
RANITIDINE HCL 71 58 28 42
JANUVIA 71 71 28 31
WARFARIN SODIUM 66 62 30 20
OMEPRAZOLE 66 64 30 9
CLOPIDOGREL 65 65 32 25
AZITHROMYCIN 59 56 33 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 58 34 50
TRIAMCINOLONE ACETONIDE 54 50 35 62
PLAVIX 54 54 35 40
METOPROLOL TARTRATE 54 49 35 18
SYMBICORT 51 49 38 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.